1. Home
  2. RLMD vs MOGU Comparison

RLMD vs MOGU Comparison

Compare RLMD & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • MOGU
  • Stock Information
  • Founded
  • RLMD 2004
  • MOGU 2011
  • Country
  • RLMD United States
  • MOGU China
  • Employees
  • RLMD N/A
  • MOGU N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • MOGU Business Services
  • Sector
  • RLMD Health Care
  • MOGU Consumer Discretionary
  • Exchange
  • RLMD Nasdaq
  • MOGU Nasdaq
  • Market Cap
  • RLMD 22.0M
  • MOGU 17.8M
  • IPO Year
  • RLMD N/A
  • MOGU 2018
  • Fundamental
  • Price
  • RLMD $0.67
  • MOGU $2.18
  • Analyst Decision
  • RLMD Buy
  • MOGU
  • Analyst Count
  • RLMD 3
  • MOGU 0
  • Target Price
  • RLMD $5.00
  • MOGU N/A
  • AVG Volume (30 Days)
  • RLMD 478.7K
  • MOGU 3.4K
  • Earning Date
  • RLMD 08-06-2025
  • MOGU 07-08-2025
  • Dividend Yield
  • RLMD N/A
  • MOGU N/A
  • EPS Growth
  • RLMD N/A
  • MOGU N/A
  • EPS
  • RLMD N/A
  • MOGU N/A
  • Revenue
  • RLMD N/A
  • MOGU $19,801,126.00
  • Revenue This Year
  • RLMD N/A
  • MOGU N/A
  • Revenue Next Year
  • RLMD N/A
  • MOGU N/A
  • P/E Ratio
  • RLMD N/A
  • MOGU N/A
  • Revenue Growth
  • RLMD N/A
  • MOGU N/A
  • 52 Week Low
  • RLMD $0.24
  • MOGU $1.81
  • 52 Week High
  • RLMD $4.47
  • MOGU $3.14
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 52.84
  • MOGU 52.62
  • Support Level
  • RLMD $0.67
  • MOGU $2.05
  • Resistance Level
  • RLMD $0.72
  • MOGU $2.17
  • Average True Range (ATR)
  • RLMD 0.08
  • MOGU 0.05
  • MACD
  • RLMD -0.03
  • MOGU 0.01
  • Stochastic Oscillator
  • RLMD 40.29
  • MOGU 92.86

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About MOGU MOGU Inc. (each representing 25)

MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.

Share on Social Networks: